Clinical Trial Update: Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring multi-omics studies on the efficacy of telitacicept in Chinese patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Fen Li | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: UNKNOWN